Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Viscoseal after arthroscopic capsular release for adhesive capsulitis of the shoulder
ISRCTN71572948Phase 4Completed
- Sponsor
- Salford Royal NHS Foundation Trust
- Start
- Apr 2014
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 4, randomised, open-label trial of sodium hyaluronate in Periarthritis humeroscapularis (2 arms), sponsored by Salford Royal NHS Foundation Trust. Primary endpoint: Constant-Murley Score at week 5. Started Apr 2014; status: completed.
02
Drugs
sodium hyaluronate
03
Conditions
Periarthritis humeroscapularis
Beyond the preview
Go deeper on ISRCTN71572948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN71572948.